Breaking News

CRO Inks OmniComm EDC Agreement

Will use TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

A full-service CRO, with global clinical operations, has signed an agreement to use TrialMaster EDC from OmniComm Systems, Inc., a provider of clinical data management technology. Under the terms of the agreement, the CRO will use OmniComm’s TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK. The CRO chose TrialMaster to complement an existing in-house EDC system and to provide additional support tools for more complex study designs. Tr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters